naltrexone

FDA Approves New Anti-Abuse Label for Embeda

FDA Approves New Anti-Abuse Label for Embeda

The Food and Drug Administration has approved new labeling for Pfizer’s Embeda extended-release capsules, an opioid pain reliever that combines morphine with naltrexone to discourage…